Nalaganje...
Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis
INTRODUCTION: This article evaluates the efficacy and safety of baricitinib 4 mg versus placebo in United States including Puerto Rico (US) and rest of the world (ROW) subpopulations using data pooled from RA-BEAM and RA-BUILD, which enrolled patients with moderate-to-severe adult-onset rheumatoid a...
Shranjeno v:
| izdano v: | Rheumatol Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935623/ https://ncbi.nlm.nih.gov/pubmed/29680881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-018-0110-x |
| Oznake: |
Označite
Brez oznak, prvi označite!
|